Nome |
# |
Thyroid Dysfunction in Primary Biliary Cholangitis: A Comparative Study at Two European Centers, file e14fb269-f5f3-3de1-e053-1705fe0ac030
|
639
|
Is osteoporosis a peculiar association with primary biliary cirrhosis?, file e14fb267-7d8a-3de1-e053-1705fe0ac030
|
247
|
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents, file e14fb269-f428-3de1-e053-1705fe0ac030
|
219
|
Heparanase and macrophage interplay in the onset of liver fibrosis, file e14fb269-f350-3de1-e053-1705fe0ac030
|
166
|
Primary Biliary Cholangitis: advances in management and treatment
of the disease, file e14fb269-fbf4-3de1-e053-1705fe0ac030
|
139
|
Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in earlyand late-stage cholestasis, file e14fb26a-5218-3de1-e053-1705fe0ac030
|
118
|
Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis, file e14fb26b-a456-3de1-e053-1705fe0ac030
|
110
|
In vitro metabolic zonation through oxygen gradient on a chip, file e14fb26c-3e48-3de1-e053-1705fe0ac030
|
93
|
Update on the Pharmacological Treatment of Primary Biliary Cholangitis, file 0c008119-6410-4566-8de9-49741c18f7b2
|
51
|
Extrahepatic autoimmunity in autoimmune liver disease, file e14fb26b-f2e4-3de1-e053-1705fe0ac030
|
48
|
Extrahepatic Malignancies in Primary Biliary Cirrhosis: A Comparative Study at Two European Centers., file e14fb267-5e3a-3de1-e053-1705fe0ac030
|
43
|
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways, file e14fb26f-136f-3de1-e053-1705fe0ac030
|
42
|
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study, file e14fb267-acbd-3de1-e053-1705fe0ac030
|
28
|
Obeticholic Acid for Primary Biliary Cholangitis, file 5b22e799-734c-48b3-ada7-f112ae6da3b6
|
27
|
Autoimmune hepatitis: Contrasts and comparisons in children and adults - a comprehensive review., file e14fb267-b3b7-3de1-e053-1705fe0ac030
|
27
|
COVID-19 and Autoimmune Liver Diseases, file bf275133-b5c9-4785-a8ae-08feddab3255
|
26
|
New therapies for primary biliary cirrhosis, file e14fb267-ac63-3de1-e053-1705fe0ac030
|
26
|
Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis, file e14fb26e-5be9-3de1-e053-1705fe0ac030
|
26
|
Plasma Adiponectin Levels in Primary Biliary Cirrhosis: A Novel Perspective for Link Between Hypercholesterolemia and Protection Against Atherosclerosis, file e14fb267-7f07-3de1-e053-1705fe0ac030
|
21
|
Epidemiology of HCV infection, file e14fb267-9c6a-3de1-e053-1705fe0ac030
|
19
|
Primary biliary cirrhosis: overlaps with other autoimmune disorders, file e14fb267-acc0-3de1-e053-1705fe0ac030
|
17
|
Real-world experience with obeticholic acid in patients with primary biliary cholangitis, file 1753c73a-f4f9-4bb2-887b-b82c3967b1f7
|
16
|
Y chromosome loss in male patients with primary biliary cirrhosis, file e14fb267-a485-3de1-e053-1705fe0ac030
|
16
|
Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome, file e14fb267-9344-3de1-e053-1705fe0ac030
|
15
|
Sleep-wake profiles in patients with primary biliary cirrhosis, file e14fb267-a484-3de1-e053-1705fe0ac030
|
13
|
Therapy of chronic hepatitis C with PEG-IFN alpha-2b plus ribavirin in patients with genotype 2 or 3: 16 versus 24 weeks, clinical outcome and direct cost analyses, file e14fb267-b3b6-3de1-e053-1705fe0ac030
|
11
|
Epidemiological aspects of biliary tree tumors in a region of northern Italy: emerging trends and sex-based differences, file e14fb267-a702-3de1-e053-1705fe0ac030
|
10
|
Hepatitis C and pregnancy, file e14fb267-ae27-3de1-e053-1705fe0ac030
|
10
|
Persistence of Anti-Hbs after up to 30 Years in Health Care Workers Vaccinated against Hepatitis B Virus, file e14fb26e-9a92-3de1-e053-1705fe0ac030
|
10
|
Primary biliary cirrhosis: report of a focus study group., file e14fb267-60ae-3de1-e053-1705fe0ac030
|
8
|
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants., file e14fb267-9c6e-3de1-e053-1705fe0ac030
|
7
|
Perspective of fixed daily dose of sofosbuvir and ledipasvir for the treatment of chronic hepatitis C, file e14fb267-acbe-3de1-e053-1705fe0ac030
|
7
|
Morning bright light treatment for sleep-wake disturbances in primary biliary cholangitis: A pilot study, file e14fb26e-7c9b-3de1-e053-1705fe0ac030
|
7
|
P.1.158: PEG-INTERFERON ALPHA-2A WITH WEIGHT-BASED RIBAVIRIN DOSES IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES: A PILOT STUDY IN A SINGLE CENTRE, file e14fb26a-947d-3de1-e053-1705fe0ac030
|
6
|
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients, file f74619f1-3840-4014-bef3-04132e4fd9f3
|
6
|
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis, file 488fd6f9-d9e9-4f87-96d8-205371ecff78
|
5
|
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid, file 8bfef657-4fed-4b48-b11f-f01cf54bc9ec
|
4
|
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis., file e14fb267-9c70-3de1-e053-1705fe0ac030
|
4
|
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies, file e14fb267-a486-3de1-e053-1705fe0ac030
|
4
|
Prediction of Iron Overload With A New Mass Spectrometry Method For Detection of Hepcidin In Plasma, file 04b14db7-8b02-42d6-a048-5c752b202e4d
|
3
|
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach, file 558de844-293c-4f14-8de3-91d3f3cb84ba
|
3
|
Greater Transplant-free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls, file a76b3902-c295-4add-b1df-63f864df7023
|
3
|
Intrahepatic cholestasis of pregnancy: new insights into its pathogenesis, file e14fb267-a487-3de1-e053-1705fe0ac030
|
3
|
Impact on follow-up strategies in patients with primary sclerosing cholangitis, file 2e6e1be4-aacc-4f24-929b-96350486e197
|
2
|
Immunogenicity of three different influenza vaccines against homologous and heterologous strains in nursing home elderly residents., file e14fb267-7e04-3de1-e053-1705fe0ac030
|
2
|
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis, file e14fb267-a489-3de1-e053-1705fe0ac030
|
2
|
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis, file e14fb26d-759c-3de1-e053-1705fe0ac030
|
2
|
Gut microbial profiling as a therapeutic and diagnostic target for managing primary biliary cholangitis, file e14fb26e-43fe-3de1-e053-1705fe0ac030
|
2
|
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data, file 00d6d020-becb-498c-b7b6-41afa05dc902
|
1
|
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis, file 317abcbd-392b-4e21-9763-064f10ff651c
|
1
|
Primary biliary cholangitis: treatment, file 41b8e632-7715-44af-8f55-265a0a361db3
|
1
|
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)), file b97558f3-8906-4b5a-9a01-3a116bf59aa6
|
1
|
Machine learning in primary biliary cholangitis: A novel approach for risk stratification, file cdcabdcc-8541-4848-9229-75126f069f53
|
1
|
A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre., file e14fb267-9d9e-3de1-e053-1705fe0ac030
|
1
|
Metabolic Syndrome Associated With Primary Biliary Cirrhosis., file e14fb267-afa1-3de1-e053-1705fe0ac030
|
1
|
The activation of NF-kB, Pregnane X Receptor, and Constitutive Androstane Receptor is modulated by the degree of cholestasis, file e14fb267-b3ee-3de1-e053-1705fe0ac030
|
1
|
Functional differentiation of human pluripotent stem cells on a chip., file e14fb269-335c-3de1-e053-1705fe0ac030
|
1
|
Primary biliary cholangitis: Old and novel therapy, file e14fb269-ee7e-3de1-e053-1705fe0ac030
|
1
|
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis, file e14fb269-eef4-3de1-e053-1705fe0ac030
|
1
|
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis, file e14fb269-f1bf-3de1-e053-1705fe0ac030
|
1
|
Geoepidemiology and changing mortality in primary biliary cholangitis, file e14fb269-f634-3de1-e053-1705fe0ac030
|
1
|
Coronary flow reserve in patients with primary biliary cholangitis, file e14fb26d-75aa-3de1-e053-1705fe0ac030
|
1
|
PBC and related extrahepatic diseases, file e14fb26d-75ac-3de1-e053-1705fe0ac030
|
1
|
Primary biliary cholangitis: Perception and expectation of illness in Italian patients, file fc24df65-581b-46c1-88fd-e295b1d62252
|
1
|
Totale |
2.329 |